Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext | Download json ]

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     ATC
 1  Agents affecting nervous system and sensory organs
   11  Agents affecting central nervous system
   12  Agents affecting peripheral nervous system
   13  Agents affecting sensory organs
     131  Ophthalmic agents
       1311  Mydriatic agents
       1312  Miotic agents
       1313  Ophthalmic local anesthetics
       1314  Ophthalmic aseptic astringents
       1315  Ophthalmic cortisones
       1316  Ophthalmic local vasoconstrictors
       1317  Ophthalmic antibiotics
       1318  Alkaloids
       1319  Others
         D00983  Triamcinolone acetonide (JP17/USP)
         D01828  Amlexanox (JP17/USAN/INN)
         D01121  Rebamipide (JP17/INN)
         D00526  Cromolyn sodium (USP); Sodium cromoglicate (JP17)
         D01081  Zinc sulfate hydrate (JP17)
         D00166  Cyanocobalamin (JP17/USP/INN)
         D00603  Timolol maleate (JP17/USP)
         D00599  Carteolol hydrochloride (JP17/USP)
         D00598  Betaxolol hydrochloride (JP17/USP)
         D03354  Hyaluronate sodium (USAN); Purified sodium hyaluronate (JP17); Sodium hyaluronate (JAN)
         D00222  Acyclovir (USP); Aciclovir (JP17/INN)
         D03332  Lysozyme hydrochloride (JP17)
         D04250  Fradiomycin sulfate and methylprednisolone
         D01730  Silver nitrate (JP17/USP)
         D00107  Tacrolimus (USP/INN); Tacrolimus hydrate (JP17)
         D00904  Diclofenac sodium (JP17/USP)
         D02076  Brimonidine tartrate (JAN/USAN)
         D00453  Ofloxacin (JP17/USP/INN)
         D00210  Norfloxacin (JP17/USP/INN)
         D00873  Lomefloxacin hydrochloride (JAN/USAN)
         D00588  Levofloxacin (USP); Levofloxacin hydrate (JP17)
         D00874  Moxifloxacin hydrochloride (JAN/USP)
         D00589  Gatifloxacin (USAN); Gatifloxacin hydrate (JP17)
         D01996  Tosufloxacin tosylate hydrate (JP17)
         D09574  Aflibercept (USAN/INN); Aflibercept (genetical recombination) (JAN)
         D00184  Cyclosporine (USP); Ciclosporin (JP17)
         D04078  Chondroitin sulfate sodium (JAN)
         D04114  Neostigmine methylsulfate and inorganic salt
         D01717  Levocabastine hydrochloride (JAN/USP)
         D01192  Olopatadine hydrochloride (JP17/USP)
         D01385  Ibudilast (JP17/INN)
         D01332  Ketotifen fumarate (JP17/USAN)
         D01713  Epinastine hydrochloride (JAN)
         D03243  Sodium borate (JP17/NF)
         D01578  Pranoprofen (JP17/INN)
         D05143  Nepafenac (JAN/USAN/INN)
         D03163  Bromfenac sodium (USAN); Bromfenac sodium hydrate (JP17)
         D04246  Fradiomycin sulfate and betamethasone sodium phosphate
         D01008  Apraclonidine hydrochloride (JAN/USP)
         D00653  Dorzolamide hydrochloride (JP17/USP)
         D00652  Brinzolamide (JAN/USP/INN)
         D10854  Brinzolamide and brimonidine tartrate
         D10512  Brinzolamide and timolol maleate
         D01025  Levobunolol hydrochloride (JAN/USP)
         D07505  Latanoprost and timolol maleate
         D08493  Dorzolamide hydrochloride and timolol maleate
         D09815  Travoprost and timolol maleate
         D10298  Brimonidine tartrate and timolol maleate
         D10569  Tafluprost and timolol maleate
         D10804  Carteolol and latanoprost
         D00356  Latanoprost (JAN/USP/INN)
         D01452  Isopropyl unoprostone (JAN)
         D02724  Bimatoprost (JAN/USAN/INN)
         D01964  Travoprost (JAN/USP/INN)
         D06274  Tafluprost (JAN/USAN/INN)
         D10966  Omidenepag isopropyl (JAN)
         D04081  Tropicamide and phenylephrine hydrochloride
         D07632  Chondroitin sulfate sodium and sodium hyaluronate
         D01162  Verteporfin (JAN/USP/INN)
         D05386  Pegaptanib sodium (JAN/USAN)
         D05697  Ranibizumab (USAN/INN); Ranibizumab (genetical recombination) (JAN)
         D11083  Brolucizumab (USAN/INN); Brolucizumab (genetical recombination) (JAN)
         D02706  Sodium gualenate hydrate (JAN)
         D04113  Boric acid and Inorganic salt
         D01089  Boric acid (JP17/NF)
         D00014  Glutathione (JP17)
         D00031  Oxiglutatione (JAN/INN)
         D01031  Helenien (JAN); Xantofyl palmitate (INN)
         D01088  Pemirolast potassium (JP17/USAN)
         D01100  Pirenoxine (JP17/INN)
         D01691  Nipradilol (JAN/INN)
         D01887  Bunazosin hydrochloride (JP17)
         D02011  Flavin adenine dinucleotide sodium (JP17)
         D02027  Tranilast (JP17/USAN/INN)
         D02264  Dipotassium glycyrrhizinate (JAN)
         D03233  Acitazanolast hydrate (JAN)
         D03864  Diquafosol tetrasodium (USAN); Diquafosol sodium (JAN)
         D04099  Erythromycin lactobionate and colistin sodium methanesulfonate
         D04106  Chloramphenicol and colistin sodium methanesulfonate (JP17)
         D04109  Glucose and inorganic salt
         D04285  Concentrated glycerin and fructose
         D07633  Chondroitin sulfate sodium and FAD sodium
         D07703  Hydroxyethyl cellulose, boric acid, dibasic sodium phosphate, potassium chloride, sodium chloride and dried sodium carbonate
         D07709  Polyvinyl alcohol and iodine
         D10463  Ripasudil hydrochloride hydrate (JAN)
A01AC01 C05AA12 D07AB09 D07XB02 H02AB08 R01AD11 R03BA06 S01BA05
A01AD07 R03DX01
A02BX14
A07EB01 D11AH03 R01AC01 R03BC01 S01GX01
A12CB01
B03BA01
C07AA06 S01ED01
C07AA15 S01ED05
C07AB05 S01ED02
D03AX05 M09AX01 R01AX09 S01KA01
D06BB03 J05AB01 S01AD03
D06BB07 J05AX02
D07CA02 S01CA08
D08AL01 S01AX02
D11AH01 L04AD02
D11AX18 M01AB05 M02AA15 S01BC03
D11AX21 S01EA05
J01MA01 S01AE01 S02AA16
J01MA06 S01AE02
J01MA07 S01AE04
J01MA12 S01AE05
J01MA14 S01AE07
J01MA16 S01AE06
J01MA22
L01XX44 S01LA05
L04AD01 S01XA18
M01AX25
N07AA51
R01AC02 S01GX02
R01AC08 S01GX09
R03DC04
R06AX17 S01GX08
R06AX24 S01GX10
S01AX07
S01BC09
S01BC10
S01BC11
S01CA05 S03CA06
S01EA03
S01EC03
S01EC04
S01EC54
S01EC54 S01ED51
S01ED03
S01ED51
S01ED51
S01ED51
S01ED51
S01ED51
S01ED55
S01EE01
S01EE02
S01EE03
S01EE04
S01EE05
S01EX06
S01FA56 S01GA55
S01KA51
S01LA01
S01LA03
S01LA04
S01LA06
S01XA01
S01XA20
S02AA03
V03AB32
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     132  Otic and nasal agents
     133  Vertigo agents
     139  Miscellaneous
   19  Other agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: May 21, 2020
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version